Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Michael Moore and Fritz Frickel join MISSION board

This article was originally published in Scrip

Executive Summary

MISSION Therapeutics, a company focused on the discovery and development of modulators of the deubiquitylating enzyme family for the treatment of cancer, has appointed Dr Michael Moore executive chair and Dr Fritz Frickel non-executive director. Dr Moore has more than two decades of senior management experience in the biotech sector, most recently as CEO of Piramed. He is currently a non-executive director of several companies including PsiOxus Therapeutics. Dr Frickel is currently an independent advisor to venture capital firms, biotech start-ups and universities, having previously served as senior vice-president of R&D and acting CEO of Alantos.

You may also be interested in...

Almirall launches Constella in six European markets

Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.

Dermira raises $35m in series B

Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.

Clovis ups public offering to $240m

Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts